[CITATION][C] Long-term management of neovascular age-related macular degeneration: to suspend or not to suspend?

RN Khurana - Ophthalmology Retina, 2019 - ophthalmologyretina.org
The long-term management of neovascular age-related macular degeneration (AMD) is
challenging because the disease is variable, chronic, and unpredictable. The variability of
the injection burden makes it difficult to use a uniform treatment regimen for each patient. 1
The chronicity of AMD reveals that care must continue beyond the 2 years reported in the
registration clinical trials. 2, 3 Finally, the unpredictability of disease recurrence makes it
unclear when to hold treatment with confidence. There is a treatment burden for the AMD …